Overview

Bioequivalence and Drug - Drug Interaction Study of Metformin/Gliclazide in Healthy Participants

Status:
Completed
Trial end date:
2018-04-29
Target enrollment:
Participant gender:
Summary
This study investigated the bioequivalence and drug-drug interaction of Metformin/Gliclazide fixed combination tablet compared to co-administration of individual tablets of Metformin and Gliclazide.
Phase:
Phase 1
Details
Lead Sponsor:
Merck KGaA
Merck KGaA, Darmstadt, Germany
Treatments:
Gliclazide
Metformin